- Corporate Officers - G
- Gridley Adam
Insider Trading History of Gridley Adam
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gridley Adam since 2009.
The trader's CIK number is 1447150.
At the time of the last reporting, Gridley Adam was the SVP, Corporate Devel of Ocugen, Inc.. (stock ticker symbol OCGN).
Also see all insider trading activities at Ocugen, Inc..
Note that in the past
Gridley Adam also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Bioform Medical Inc (BFRM) by Gridley Adam
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | BFRM | 0 | $0 | 33,438 | $95,511 | 33,438 | $26,345 |
Yearly summary of insider trading at Ocugen, Inc. (HSGX) by Gridley Adam
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | HSGX | 2,000 | $4,300 | 0 | $0 | 0 | $0 |
| 2016 | HSGX | 5,000 | $10,040 | 0 | $0 | 0 | $0 |
Insider trading activities at 2 companies by Gridley Adam:
1. Bioform Medical Inc (BFRM)
2. Ocugen, Inc. (HSGX)
Table 1. Insider trading of Bioform Medical Inc (BFRM) by Gridley Adam
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-08-25 | BFRM | Sale | 24,500 | 2.83 | 69,359 |
| 2009-08-24 | BFRM | Sale | 8,938 | 2.93 | 26,152 |
| 2009-08-25 | BFRM | Option Ex | 24,500 | .84 | 20,580 |
| 2009-08-24 | BFRM | Option Ex | 8,938 | .65 | 5,765 |
Table 2. Insider trading of Ocugen, Inc. (HSGX) by Gridley Adam
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-05-16 | HSGX | Buy | 2,000 | 2.15 | 4,300 |
| 2016-12-01 | HSGX | Buy | 5,000 | 2.01 | 10,040 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Gridley Adam
(SVP, Corporate Devel of Ocugen, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.